The Influence of Circulating Immune Cell and CA125 Dynamics on Neoadjuvant Therapy Selection for Advanced Ovarian Cancer

The Influence of Circulating Immune Cell and CA125 Dynamics on Neoadjuvant Therapy Selection for Advanced Ovarian Cancer

<i>Background and Objectives:</i> Ovarian cancer, including tubal and peritoneal cancer, is the third most common gynecological cancer and the leading cause of death from gynecological malignancies in developed countries. This study explores the prognostic value of the neutrophil-to-lymp...

Full description

Bibliographic Details
Main Authors: Alexandra Lazar, Ana Maria Popa, Cristina Orlov-Slavu, Horia-Teodor Cotan, Cristian Ion Iaciu, Cristina Mihaela Olaru, Oliver Daniel Schreiner, Romeo Cristian Ciobanu, Cornelia Nitipir
Format: Article
Language:English
Published: MDPI AG 2024-08-01
Series:Medicina
Subjects:
circulating immune cell
ovarian cancer
neoadjuvant therapy
baseline NLR
post-therapeutic NLR
Online Access:https://www.mdpi.com/1648-9144/60/8/1290

Internet

https://www.mdpi.com/1648-9144/60/8/1290

Similar Items